THERASPHERE ADMIN SET, Article No. 7M2650. Canada only. Sterile, single use administration set used to...
B. Braun Medical, Inc. began a recall of THERASPHERE ADMIN SET, Article No. 7M2650. Canada only. Sterile, single use administration set used to deliver Yttrium-90 glass microspheres for internal... on . FDA classified it as Class II and gives the reason as "Devices may leak as a result of a manufacturing issue. Leakage may result in a delay of therapy, increase risk of bloodstream infection (BSI), and may expose both patients and healthcare workers to hazardous medication...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.
Recall record
- Recall number
- Z-0133-2024
- Classification
- Class II
- Status
- Open, Classified
- Initiated
- Posted
- Recalling firm
- B Braun Medical Inc
- Product
- THERASPHERE ADMIN SET, Article No. 7M2650. Canada only. Sterile, single use administration set used to deliver Yttrium-90 glass microspheres for internal radiation therapy.
- Product code
- ONB Closed Antineoplastic And Hazardous Drug Reconstitution And Transfer System
- Reason for recall
- Devices may leak as a result of a manufacturing issue. Leakage may result in a delay of therapy, increase risk of bloodstream infection (BSI), and may expose both patients and healthcare workers to hazardous medication. There is also the potential for life-threatening situations to occur requiring additional medical intervention.
- Root cause tag
- manufacturing process
- FDA root cause
- Process control
- Action
- On September 26, 2023, the firm notified customers via Urgent Product Recall Notification letters. Customers were informed of the potential for leakage at the male Luer lock site. Customers were instructed to report total amount of impacted product on hand to the firm, after which B Braun Customer Support will contact the customer with instructions on how to return the product for credit or replacement depending on the customer's need. Questions about this recall may be reported to BBMI s Postmarket Surveillance Department by calling 1-833-425-1464.
- Quantity in commerce
- 760 units
- Distribution
- Worldwide distribution - US Nationwide and the countries of Canada and Singapore.
- Product codes and lots
- UDI-DI: 5060116920635 Lot 0061790166
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-0128-2024 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-0129-2024 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-0130-2024 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-0131-2024 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-0132-2024 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-0133-2024 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-0134-2024 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-0135-2024 | Class II | Ongoing | Voluntary: Firm initiated | ||
| Z-0136-2024 | Class II | Ongoing | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
